Obesity costs US firms up to $45B a year

13 April 2008

The rate of obesity in the USA has doubled in the last 30 years, and those extra pounds weigh on companies' bottom lines, according to a new report from The Conference Board. Today, 34% of American adults fit the definition of "obese." These employees cost US private employers an estimated $45.0 billion annually in medical expenditures and work loss.

In a new report, Weights and Measures: What Employers Should Know about Obesity, The Conference Board examines the financial and ethical questions surrounding whether and how, US companies should address the obesity epidemic.

"Employers need to realize that obesity is not solely a health and wellness issue," says labor economist Linda Barrington, Research Director of The Conference Board Management Excellence Program and co-author of the report. "Employees' obesity-related health problems in the USA are costing companies billions of dollars each year in medical coverage and absenteeism. Employers need to pay attention to their workers' weights, for the good of the bottom line, as well as the good of the employees and of society," she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight